Why did Federal Reserve lift Wells Fargo asset cap?
How will Trump’s doubled steel tariffs impact economy?
What caused Nvidia’s $1 trillion market rally?
Why is Meta investing in nuclear power for AI?
How are Trump’s tariffs reshaping startups and VCs?
What’s behind CrowdStrike’s weak revenue guidance?
Why is Dollar General attracting higher-income shoppers?
Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy?
finance.yahoo.com/news/beaten-down-summit-therapeutics-stock-092300133.html
In This Article:
Key Points
-
Summit Therapeutics stock fell hard recently in response to disappointing clinical trial results.
-
Ivonescimab failed to produced a statistically significant overall survival benefit in the phase 3 Harmoni trial.
-
Ivonescimab has been approved by Chinese…
This story appeared on finance.yahoo.com, 2025-06-02 09:23:00.